Publication
  • EHA •
  • 14 June, 2025 •
  • •

Benefit of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria irrespective of baseline transfusion status

Britta Höchsmann, Ana Boban, Marta Morado, Peter Hillmen, Sheena Patel, Johan Szamosi, Elena Surova, Jens Panse

Available materials

Poster
Publication
  • EHA •
  • 14 June, 2025 •
  • •

A benefit assessment of pegcetacoplan dose increase in the Phase 3 PEGASUS trial of PNH patients with difficult-to-control disease

Morag Griffin, Alexander Röth, Brian Mulherin, Elena Surova, Regina Horneff, Peter Hillmen, Régis Peffault de Latour

Available materials

Poster
Publication
  • EHA •
  • 13 June, 2025 •
  • •

Early response in complement inhibitor naïve patients with paroxysmal nocturnal hemoglobinuria treated with pegcetacoplan in the Phase 3 PRINCE trial

Austin G. Kulasekararaj, Elena Solomou, Christopher Patriquin, Peter Hillmen, Sheena Patel, Johan Szamosi, Elena Surova, Alexander Röth

Available materials

Poster
Publication
  • EHA •
  • 13 June, 2025 •
  • •

Interim analysis of the ongoing COMPLETE study on the real-world effectiveness of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria (PNH)

Régis Peffault de Latour, Roochi Trikha, Lenka Mastíková, Carmen Gonzalez Gonzalez, Håkan Malmström, Stefan Lethagen

Available materials

Poster
Sign up for alerts